MedTrace Logo

Positive Affect Promotion to Empower Optimal Adherence to HIV Therapy

NCT04035759 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-11-01

No results posted yet for this study

Summary

This study assesses the feasibility and acceptability of the APPEAL program, a 3-session intervention designed to promote positive affect among men and women living with HIV infection. Forty participants will be randomly assigned to receive the APPEAL program, and another 40 will receive standard of care. All participants will complete self-reported assessments at baseline and at 3 and 6 months, and will have their HIV antiretroviral medication adherence monitored as part of study participation.

Conditions

Interventions

BEHAVIORAL

APPEAL

Three-session, individually administered program, with sessions spaced monthly. Optional weekly contacts with participants to support engagement in program exercises/activities.

Sponsors & Collaborators

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • State University of New York - Downstate Medical Center

    lead OTHER

Principal Investigators

  • Tracey Wilson, PhD · SUNY Downstate Health Sciences University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-16
Primary Completion
2021-04-26
Completion
2021-04-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04035759 on ClinicalTrials.gov